Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

A meeting of the CMO Welsh Office was held "to establish the known facts as they affected the UK in general and Wales in the particular."

Published on: 24 September, 2024

A Welsh Office representative was invited to attend the meetings of the Advisory Group on Hepatitis and the Working Group on AIDS of the Advisory Committee on the NBTS.

Published on: 24 September, 2024

A ban on Factor 8 from the US was considered at a meeting on AIDS convened by the Welsh Office, Medical Service Health Professional Group. It was argued that this would cause a reduction in patients treated and the modification of the facility for home treatment.

Published on: 24 September, 2024

A meeting on AIDS was convened by the Welsh Office, Medical Services Health Professional Group. It was attended by Dr Gareth Crompton, the Chief Medical Officer, and a number of medical officers.

Published on: 24 September, 2024

Dr David Ferguson-Lewis wrote to the Parliamentary Under-Secretary of State notifying him that the patient at the Cardiff Haemophilia Centre did meet the CDSC definition of AIDS but there was "no cause for precipitate action."

Published on: 24 September, 2024

Dr David Ferguson-Lewis wrote to the Parliamentary Under-Secretary of State following press reports implicating US blood products in cases of AIDS.

Published on: 24 September, 2024

The Welsh Office issued advice and took action "on its own account", such as issuing PSM (84)4, asking doctors to inform the Communicable Disease Surveillance Centre of cases of AIDS or Kaposi's sarcoma.

Published on: 24 September, 2024

Dr J Skone wrote to chief administrative medical officers stating that he was aware of a haemophilia patient suffering from AIDS.

Published on: 24 September, 2024

Dr Nicol Spence Galbraith wrote to venereologists and dermatologists in England and Wales seeking their "cooperation" in a trial clinical reporting system of Kaposi's sarcoma due to the "inadequacies of existing surveillance systems".

Published on: 24 September, 2024

When the SHHD became aware that the Edinburgh and South East Scotland's leaflet had started circulate, Dr Bell commented that it "looks as though, de facto, we are about to reach a situation in which there will be two slightly different leaflets."

Published on: 24 September, 2024

At the meeting it was stated that "at present there was no proof that the commercial concentrates were the cause of AIDS" and "it was agreed that patients...should continue to receive the NHS or commercial concentrates in their usual way."

Published on: 24 September, 2024

Dr Brookes told the SNBTS directors' meeting that "the only Scottish region to continue holding sessions" was now Glasgow, which held its final session on 25 March 1984.

Published on: 24 September, 2024

It was reported that there was a frequency of Hepatitis B in various donor groups, including new general public and factory donors, Armed Forces personnel, and inmates from prisons and borstals.

Published on: 24 September, 2024

Paul Winstanley stated "We shall obviously need to liaise closely with Home Office also since they have in the past been very much in favour of blood donation by prisoners."

Published on: 24 September, 2024

The MRC's Blood Transfusion Research Committee was disbanded in July 1982, due to the MRC board's conclusion that its work was being duplicated elsewhere.

Published on: 24 September, 2024

Statistics following the emergence of AIDS in Los Angeles during 1981, where discussions around the disease were taking place including how the disease was described as an outbreak of "community acquired" pneumocystis carinii pneumonia.

Published on: 24 September, 2024

By the time the AIDS leaflet were used in South East Scotland, the group of those identified as at risk in Scotland had been amended.

Published on: 24 September, 2024

Following discussions of the wording and production of the AIDS leaflet in 1983, it was highlighted that it was believed that AIDS could be transmitted through blood and blood products including Factor 8.

Published on: 24 September, 2024

Professor Hann stated that a lack of centralised government resulted in a failure to recognise the risks.

Published on: 24 September, 2024

Dr Scott described regular meetings between the SHHD and the DHSS and ongoing communication with regards to the discussion of the risks of AIDS but clarified that the SHHD did not automatically adopt DHSS policies.

Published on: 24 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2113
  • Page 2114
  • Page 2115
  • Page 2116
  • Current page 2117
  • Page 2118
  • Page 2119
  • Page 2120
  • Page 2121
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.